Dynamic Blood Concentrations of Aβ1–40 and Aβ1–42 in Alzheimer’s Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dynamic Blood Concentrations of Aβ1–40 and Aβ1–42 in Alzheimer’s Disease
Authors
Keywords
-
Journal
Frontiers in Cell and Developmental Biology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-08-11
DOI
10.3389/fcell.2020.00768
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
- (2019) Young Chul Youn et al. Alzheimers Research & Therapy
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Defeating Alzheimer's disease and other dementias: a priority for European science and society
- (2016) Bengt Winblad et al. LANCET NEUROLOGY
- Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials
- (2015) Michael C. Donohue et al. Alzheimers & Dementia
- Label-free detection of ApoE4-mediated β-amyloid aggregation on single nanoparticle uncovering Alzheimer's disease
- (2015) Min Kyung Kang et al. BIOSENSORS & BIOELECTRONICS
- CSF biomarker variability in the Alzheimer's Association quality control program
- (2013) Niklas Mattsson et al. Alzheimers & Dementia
- Reference measurement procedures for Alzheimer’s disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42
- (2012) Niklas Mattsson et al. Biomarkers in Medicine
- Stability of amyloid-β peptides in plasma and serum
- (2012) Mirko Bibl et al. ELECTROPHORESIS
- Longitudinal plasma amyloid beta as a biomarker of Alzheimer’s disease
- (2012) Robert A. Rissman et al. JOURNAL OF NEURAL TRANSMISSION
- The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers
- (2011) Niklas Mattsson et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants
- (2011) Richard Mayeux et al. NEUROBIOLOGY OF AGING
- Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall
- (2010) Niklas Mattsson et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
- (2009) Tero Tapiola et al. ARCHIVES OF NEUROLOGY
- Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
- (2008) O. L. Lopez et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started